Literature DB >> 29393226

2018 Update on Intravitreal Injections: Euretina Expert Consensus Recommendations.

Andrzej Grzybowski1,2, Reinhard Told3, Stefan Sacu3, Francesco Bandello4, Elad Moisseiev5, Anat Loewenstein5,5, Ursula Schmidt-Erfurth3.   

Abstract

Intravitreal injections (IVI) have become the most common intraocular procedure worldwide with increasing numbers every year. The article presents the most up-to-date review on IVI epidemiology and techniques. Unfortunately, important issues related to pre-, peri- and postinjection management lack randomized clinical trials for a final conclusion. Also, a great diversity of approaches exists worldwide. Therefore, expert consensus recommendations on IVI techniques are provided.
© 2018 S. Karger AG, Basel.

Keywords:  Intravitreal injections; Treatment of retinal diseases; Vitreoretinal diseases

Mesh：

Year:  2018        PMID： 29393226     DOI： 10.1159/000486145

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN： 0030-3755            Impact factor:   3.250


  72 in total

1.  Real-World Trends in Intravitreal Injection Practices among American Retina Specialists.

Authors:  Rahul Chaturvedi; Kendall W Wannamaker; Paul J Riviere; Arshad M Khanani; Charles C Wykoff; Daniel L Chao
Journal:  Ophthalmol Retina       Date:  2019-04-04

Review 2.  Advances in ocular drug delivery systems.

Authors:  Jennifer J Kang-Mieler; Kayla M Rudeen; Wenqiang Liu; William F Mieler
Journal:  Eye (Lond)       Date:  2020-02-18       Impact factor: 3.775

3.  siRNA Therapeutics in Ocular Diseases.

Authors:  Javier Moreno-Montañés; Anne-Marie Bleau; Tamara Martínez; Beatriz Vargas; María Victoria González; Ana Isabel Jiménez
Journal:  Methods Mol Biol       Date:  2021

Review 4.  Newly identified sleep-wake and circadian circuits as potential therapeutic targets.

Authors:  Anne Venner; William D Todd; Jimmy Fraigne; Hannah Bowrey; Ada Eban-Rothschild; Satvinder Kaur; Christelle Anaclet
Journal:  Sleep       Date:  2019-05-01       Impact factor: 5.849

5.  Ophthalmic photographer virtual clinics in medical retina.

Authors:  Abdul R El-Khayat; Rossella Anzidei; Vasileios Konidaris
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

6.  Outcome Predictors of SD-OCT-Driven Intravitreal Ranibizumab in Choroidal Neovascularization due to Myopia.

Authors:  Maria-Magdalena Guichard; Géraldine Peters; Cengiz Tuerksever; Christian Pruente; Katja Hatz
Journal:  Ophthalmologica       Date:  2019-08-06       Impact factor: 3.250

7.  In vitro release of hydrophobic drugs by oleogel rods with biocompatible gelators.

Authors:  Russell Macoon; Mackenzie Robey; Anuj Chauhan
Journal:  Eur J Pharm Sci       Date:  2020-06-12       Impact factor: 4.384

8.  Effect of Intravitreal Injections on Retinal Imaging Metrics in Glaucomatous and Non-Glaucomatous Eyes.

Authors:  Ronaldo Nuesi; Swarup S Swaminathan
Journal:  Curr Ophthalmol Rep       Date:  2020-06-04

9.  Ophthalmic delivery of hydrophilic drugs through drug-loaded oleogels.

Authors:  Russell Macoon; Anuj Chauhan
Journal:  Eur J Pharm Sci       Date:  2020-11-01       Impact factor: 4.384

10.  Predictors for 2-Year Functional and Morphological Outcomes of a Treat-and-Extend Regimen with Ranibizumab in Patients with Diabetic Macular Edema.

Authors:  Helena Giannakaki-Zimmermann; Alexandra Behrndt; Laura Hoffmann; Maria-Magdalena Guichard; Cengiz Türksever; Christian Prünte; Katja Hatz
Journal:  Ophthalmic Res       Date:  2021-01-26       Impact factor: 2.892
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.